

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
CLDX
Celldex Therapeutics
$26.72
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Chart
$26.19 (+2.02%)
$22.19 (+20.41%)
$19.67 (+35.84%)
$26.47 (+0.94%)
CLDX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

CLDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CLDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLDX Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CLDX current stock price?
What are CLDX stock strengths?
What risks are associated with CLDX stock?
When is CLDX next earnings report?
What is CLDX market cap and volume?
What is CLDX's current Stock IQ?
Should I buy CLDX stock right now?
Is CLDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for CLDX?
What does a 'Strong Sell' rating mean for CLDX?
What factors influence CLDX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
CLDX
Celldex Therapeutics
Current Price
$26.72
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Chart
$26.19 (+2.02%)
$22.19 (+20.41%)
$19.67 (+35.84%)
$26.47 (+0.94%)
CLDX Analysts Opinion
CLDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CLDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLDX Street view is bullish and have positive views on the near-term outlook
CLDX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
CLDX Latest Analysis
Mizuho Initiates Coverage of Celldex Therapeutics (CLDX) with Outperform Recommendation. Fintel reports that on October 21 2025 Mizuho initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a Outperform recommendation. Analyst Price Forecast Suggests 107.35% Upside
Tue Oct 21, 2025
Barclays Initiates Coverage of Celldex Therapeutics (CLDX) with Underweight Recommendation. Fintel reports that on October 13 2025 Barclays initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a Underweight recommendation. Analyst Price Forecast Suggests 111.40% Upside
Tue Oct 14, 2025
Analyst Expectations For Celldex Therapeuticss Future. Analysts'. ratings for Celldex Therapeutics (NASDAQ:) over the last quarter vary from ish to bearish as provided by 6 analysts.In the table below you'.ll find a summary of their recent ratings revealing the shifting sentiments over the past 30 days and comparing them to the previous months.4101000010100003100000000In the assessment of 12-month price targets analysts unveil insights for Celldex Therapeutics presenting an average targe
Mon Oct 13, 2025
Celldex Therapeutics: Caution Warranted After Big Rebound (Rating Downgrade).
Mon Oct 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CLDX Stock trends
CLDX Stock performance
CLDX Stock analysis
CLDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.